Britain's biggest pharma company on Thursday said it had paid $28.5m (£17.7m) in 2010 to institutions involved in 127 studies, with 595 different lead researchers.
They conducted research on areas including cancer and payments included costs to conduct research such as diagnostic tests.
The drug giant has previously given details on payments to speakers and in the latest figures, also revealed on Thursday, GSK said it paid out $56.8m last year to 5,331 US health care professionals for speaking on behalf of GSK or giving it advice.
That compared with $51m in the last nine months of 2009, when GSK started detailing such payments.
Friday, April 01, 2011
GlaxoSmithKline reveals fees paid to US doctors - Telegraph